A detailed history of Frontier Wealth Management LLC transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Frontier Wealth Management LLC holds 50,000 shares of CGTX stock, worth $22,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$22,000
Previous $152,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$2.41 - $6.9 $120,500 - $345,000
50,000 New
50,000 $152,000

Others Institutions Holding CGTX

About COGNITION THERAPEUTICS INC


  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $9.99M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.